ATE318328T1 - Diagnostika und therapeutika für osteoporose - Google Patents

Diagnostika und therapeutika für osteoporose

Info

Publication number
ATE318328T1
ATE318328T1 AT00961425T AT00961425T ATE318328T1 AT E318328 T1 ATE318328 T1 AT E318328T1 AT 00961425 T AT00961425 T AT 00961425T AT 00961425 T AT00961425 T AT 00961425T AT E318328 T1 ATE318328 T1 AT E318328T1
Authority
AT
Austria
Prior art keywords
osteoporosis
diagnostics
therapeutic products
therapeutic
products
Prior art date
Application number
AT00961425T
Other languages
English (en)
Inventor
Dijk Simon Van
Gordon W Duff
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Application granted granted Critical
Publication of ATE318328T1 publication Critical patent/ATE318328T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
AT00961425T 1999-08-30 2000-08-30 Diagnostika und therapeutika für osteoporose ATE318328T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15146099P 1999-08-30 1999-08-30

Publications (1)

Publication Number Publication Date
ATE318328T1 true ATE318328T1 (de) 2006-03-15

Family

ID=22538869

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00961425T ATE318328T1 (de) 1999-08-30 2000-08-30 Diagnostika und therapeutika für osteoporose

Country Status (11)

Country Link
US (2) US6558905B1 (de)
EP (1) EP1212464B1 (de)
JP (1) JP2004504802A (de)
AT (1) ATE318328T1 (de)
AU (2) AU785040B2 (de)
BR (1) BR0014150A (de)
CA (1) CA2382848C (de)
DE (1) DE60026150T2 (de)
ES (1) ES2261239T3 (de)
MX (1) MXPA02002251A (de)
WO (1) WO2001016377A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1194590A2 (de) * 1999-06-30 2002-04-10 Interleukin Genetics, Inc. Diagnostika und therapeutika für krankheiten assoziiert mit einem il-1 inflammatorischen haplotyp
US7723028B2 (en) 2000-08-30 2010-05-25 Interleukin Genetics, Inc. Diagnostics and therapeutics for osteoporosis
US20090023147A1 (en) * 1999-08-30 2009-01-22 Kenneth Kornman Diagnostics and therapeutics for osteoporosis
WO2004065939A2 (en) * 2003-01-16 2004-08-05 Decode Genetics Ehf. Methods for diagnosing osteoporosis or a susceptibility to osteoporosis based on haplotype association
CN100424182C (zh) * 2001-06-15 2008-10-08 白介素遗传公司 衰老相关疾病早期发作的检测与治疗方法
TWI346700B (en) * 2002-01-25 2011-08-11 Interleukin Genetics Inc The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes
US20070264645A1 (en) * 2002-01-25 2007-11-15 Kenneth Kornman IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
AU2003265676A1 (en) * 2002-08-24 2004-03-11 Creighton University Methods for detecting genes associated with bone properties and/or height
US7353662B2 (en) * 2004-12-22 2008-04-08 York International Corporation Medium voltage starter for a chiller unit
US8590329B2 (en) 2004-12-22 2013-11-26 Johnson Controls Technology Company Medium voltage power controller
EP1951903A2 (de) * 2005-10-25 2008-08-06 Interleukin Genetics, Inc. Der il-1-gencluster und damit assoziierte entzündungspolymorphismen und haplotypen
CA2668722A1 (en) * 2006-11-15 2008-05-22 Interleukin Genetics, Inc. The il-1 gene cluster, insulin resistance and coronary artery disease associated polymorphisms and haplotypes and methods of using same
WO2017123696A1 (en) 2016-01-12 2017-07-20 Interleukin Genetics, Inc. Methods for predicting response to treatment
US10337070B2 (en) 2017-01-12 2019-07-02 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
EP3980561A1 (de) 2019-06-06 2022-04-13 Sitokine Limited Zusammensetzungen und verfahren zur behandlung von lungen-, kolorektal- und brustkrebs
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311018D0 (en) 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
CA1316520C (en) 1987-05-19 1993-04-20 Larry C. Hamilton Valve
FR2650840B1 (fr) 1989-08-11 1991-11-29 Bertin & Cie Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
WO1993011149A1 (en) 1991-12-03 1993-06-10 Thomas Jefferson University Methods of detecting a genetic predisposition for osteoporosis
EP0652975B1 (de) 1992-07-31 2004-10-13 Garvan Institute Of Medical Research Einschätzung von in trans-agierenden faktoren der allelen variation
DE69333641T2 (de) 1992-12-28 2005-11-03 Baylink, David Jeston, Redlands Methode zur messung der knochenresorption
IL108947A0 (en) 1993-03-12 1994-06-24 Osteopharm Ltd Bone stimulating factor
CA2164498C (en) 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
US5698399A (en) * 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis
GB9706359D0 (en) 1997-03-27 1997-05-14 Gemini International Holdings Polymorphisms of an il-1 receptor antagonist gene
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease

Also Published As

Publication number Publication date
DE60026150T2 (de) 2006-11-16
JP2004504802A (ja) 2004-02-19
CA2382848A1 (en) 2001-03-08
AU785040B2 (en) 2006-08-31
MXPA02002251A (es) 2003-08-20
EP1212464A2 (de) 2002-06-12
ES2261239T3 (es) 2006-11-16
US6558905B1 (en) 2003-05-06
AU2006203097A1 (en) 2006-08-17
CA2382848C (en) 2011-01-04
BR0014150A (pt) 2002-05-14
AU2006203097B2 (en) 2009-03-12
EP1212464B1 (de) 2006-02-22
US20040110168A1 (en) 2004-06-10
AU7338000A (en) 2001-03-26
WO2001016377A2 (en) 2001-03-08
WO2001016377A3 (en) 2002-01-17
DE60026150D1 (de) 2006-04-27

Similar Documents

Publication Publication Date Title
ATE318328T1 (de) Diagnostika und therapeutika für osteoporose
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
PT1446387E (pt) Derivados de aril-1,4-pirazina substituídos
DE69927823T2 (de) Hydrogel für die therapeutische behandlung von aneurysmas
MY130489A (en) Substituted aryl 1, 4-pyrazine derivatives
DE60023043D1 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
DE69826999D1 (de) Modulare, platzsparende und multidirektionelle osteosynthesevorrichtung für die wirbelsäule
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
ATE422498T1 (de) Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems
ATE319439T1 (de) Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
DE69937515D1 (de) Chirurgische Vorrichtung für die Hornhaut
DE29713859U1 (de) Vorrichtung zur Herstellung von Saucen, Teigen o.dgl.
TR200200278T2 (tr) Kalsilitik bileşimler
BR0314139A (pt) Derivados de 1,4-pirazina substituìdos
ATE277924T1 (de) Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression
NO20005548L (no) Mykobakterieinhibitorer
NZ514691A (en) Method to type prion proteins
WO2002072883A3 (de) Nukleotidträger zur diagnose und therapie oraler erkrankungen
DE59808637D1 (de) Vorrichtung für die behandlung von flüssigkeiten
DE29707771U1 (de) Einrichtung zur Bestimmung von endexpiratorischen Gasen, insbes. für die Ovulationszeitpunktbestimmung
DK1133297T3 (da) Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin
DK1332229T3 (da) Fremgangsmåde til screening af midler til at behandle overvægt
DE29505076U1 (de) Fußraspel, namentlich für Hautpflege
IT1280629B1 (it) Tripeptide per il trattamento delle forme cancerose, in particolare per il trattamento del melanoma.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties